SEC Tracker
Get the app

iRhythm Holdings IRTC

iRhythm Holdings reports Q3 2026 financial results

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Revenue of $221.6 million, up 14.9% from Q3 2025
  2. GAAP net loss of $29.9 million, up from $5.2 million in Q3 2025
  3. Adjusted EBITDA of $51.2 million, up $29.6 million from Q3 2025
  4. Raised 2026 revenue guidance to $890 million to $895 million

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when iRhythm Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Merit Medical Systems MMSI public float $5.4B, Jun 30, 2025
  2. TransMedics Group TMDX public float $4.4B, Jun 30, 2025
  3. Integer Holdings ITGR public float $4.3B, Jun 27, 2025
  4. GLAUKOS GKOS public float $5.9B, Jun 30, 2025
  5. Masimo MASI public float $3.9B, Jun 28, 2025